Patents Assigned to Squarox, LLC
  • Non-specific delayed-type hypersensitivity response to treat herpes simplex virus infection
    Patent number: 10940197
    Abstract: A method is presented for treating herpes simplex virus (HSV) infection comprising: (a) locally administering a substance that induces a delayed type hypersensitivity (DTH) response to a patient at a site of an HSV lesion to induce a DTH response at the site of the lesion during one or more outbreaks of the HSV infection.
    Type: Grant
    Filed: January 28, 2019
    Date of Patent: March 9, 2021
    Assignee: Squarox, LLC
    Inventor: Hugh McTavish